Aetna Inc. Stock
-
Your prediction
Pros and Cons of Aetna Inc. in the next few years
Pros
Cons
Performance of Aetna Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Aetna Inc. | - | - | - | - | - | - | - |
| Centene Corp. | 0.620% | 3.097% | 7.101% | 105.281% | 67.520% | -4.501% | -8.063% |
| Humana Inc. | 0.580% | -0.575% | 13.816% | 71.033% | 57.559% | -11.780% | -10.825% |
| Cigna Corp. | 1.620% | 4.061% | 0.000% | -6.148% | 7.079% | -0.672% | 25.550% |
News
ARS Pharmaceuticals Q1 Earnings Call Highlights
ARS Pharmaceuticals (NASDAQ:SPRY) reported first-quarter 2026 revenue of $22.7 million as executives said the company is working to expand access, reduce prescribing friction and build momentum for
CVS Health Q1 Earnings Call Highlights
CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with
Is CVS Health the Ultimate Value Stock to Buy Right Now?
Shares of CVS Health (NYSE: CVS) have lagged the S&P 500 in total return this year, reinforcing a familiar narrative about the healthcare company: a mature, slow-growing grinder.
However, that view


